Head to head
Novo-Nordisk A/S vs Eli Lilly and Co
Side-by-side on the measures that matter, with a plain-English read. Full detail: NVO · LLY
NVO
Novo-Nordisk A/S
38.64+1.20%
1-year price shape — -31% over the period
Quant Rating E · 11/100
vs
LLY
Eli Lilly and Co
1,179.27+0.83%
1-year price shape — +39% over the period
Quant Rating B · 77/100
1-year performance, rebased to 100
Novo-Nordisk A/S edges it on the scoreable measures. Novo-Nordisk A/S trades cheapest on trailing earnings; Novo-Nordisk A/S pays the highest dividend yield.
| NVO | LLY | |
|---|---|---|
| Snapshot | ||
| Sector | Drug Manufacturers - General | Drug Manufacturers - General |
| Last price | 38.64 | 1,179.27 |
| Change today | +1.20% | +0.83% |
| 1-year return | -31.0% | +38.7% |
| Market cap | $172.53B | $1.11T |
| 52-week range | 34.20 – 61.21 | 778.93 – 1,292.65 |
| Valuation | ||
| P/E (TTM) | 9.84 | 39.59 |
| P/E percentile, own 5-yr range | 0th | 6th |
| P/B | 5.20 | 32.77 |
| Dividend yield | 4.62% | 0.55% |
| Profitability & growth | ||
| EPS (TTM) | 3.45 | 22.95 |
| Net profit (TTM) | $15.41B | $21.60B |
| Revenue (TTM) | $329.43B | $79.67B |
| Revenue growth (YoY) | +2.1% | +47.7% |
| Gross margin | 80.6% | 83.4% |
| Operating margin | 43.1% | 49.7% |
| Net margin | 35.3% | 33.5% |
| Free cash flow (TTM) | $30.89B | $13.56B |
| Ownership & sentiment | ||
| Institutional ownership | 55.7% | 79.3% |
| Insider activity (12mo) | 0 buy / 0 sell | 37 buy / 13 sell |
| Short interest (% of float) | 0.7% | 0.7% |
| Analyst consensus | 80% hold / 20% sell (5) | 91% buy / 5% hold / 5% sell (22) |
| Analyst price target | $43 (+12%) | $1,383 (+17%) |
| StockVane view | ||
| StockVane Quant Rating | E (11) | B (77) |
| Company | ||
| Employees | 69,505 | 50,000 |
| Founded | 1923 | 1876 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.